MEDNAX's (MD) Q1 results reflect the coronavirus adversities that drained its revenues and volumes.

Q1 2020 MEDNAX Inc Earnings Call

MEDNAX, Inc. today announced the proactive steps it has been taking in response to the rapidly evolving Coronavirus (COVID-19) pandemic.

MD earnings call for the period ending March 31, 2020.

MEDNAX's (MD) affiliate Jefferson Radiology collaborates with CDI for providing enhanced healthcare services to the Springfield community.

MEDNAX (MD) takes several steps to help fight the COVID-19 pandemic.

Moody's Investors Service ("Moody's") changed MEDNAX, Inc.'s ("MEDNAX") outlook to negative from stable. At the same time, Moody's affirmed the company's B1 Corporate Family Rating, the B1-PD Probability of Default Rating and the B1 ratings on its unsecured bonds due in 2023 and 2027. There is no change to the company's SGL-2 Speculative Grade Liquidity Rating.

Even though MEDNAX (MD) endures the COVID-19 impact on global economy, it holds prospects to revive its fortunes with the help of its initiatives and strong fundamentals.

Mark Roberts of Off Wall Street has been advising hedge funds for 30 years. Why he’s bearish on a software firm and a lubricants maker—and bullish on a gold stock.

Jefferson Radiology, an affiliate of MEDNAX and Center for Diagnostic Imaging launch new collaborative partnership.

Even though MEDNAX (MD) endures the COVID-19 impact on global economy, it holds high prospects to revive its fortunes by virtue of its solid fundamentals.

Owl Creek Asset Management increased its stake in wireless-communications firm Anterix, while Paulson & Co. bought more Bausch stock.

Mednax (MD) delivered earnings and revenue surprises of -23.81% and 1.29%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Moody's Investors Service, ("Moody's") today announced rating actions on 9 US healthcare services companies with businesses in physician staffing, travel nurse, locum tenens, radiology and diagnostic imaging to reflect the expected impact of business disruption caused by the coronavirus outbreak. As providers of various types of healthcare services, these companies are exposed to declining demand for their services due to factors including the postponement of elective procedures, lower emergency department volumes and closure of many non-emergent healthcare facilities. The US healthcare services sector has been one of the sectors affected by the shock given government and health association guidance to postpone all non-emergent healthcare services and take self-isolation measures.

MEDNAX 2020 First Quarter Conference Call/Webcast Scheduled for Thursday, May 7, 2020

Shares of Mednax (NYSE:MD) fell 10% after the company reported Q1 results.Quarterly Results Earnings per share fell 50.77% over the past year to $0.32, which missed the estimate of $0.56.Revenue of $845,918,000 lower by 0.62% year over year, which missed the estimate of $856,420,000.Looking Ahead Earnings guidance hasn't been issued by the company for now.Revenue guidance hasn't been issued by the company for now.How To Listen To The Conference Call Date: May 07, 2020View more earnings on MDWebcast URL: https://edge.media-server.com/mmc/p/pfdzzn4qRecent Stock Performance 52-week high: $29.97Company's 52-week low was at $7.37Price action over last quarter: down 35.97%Company Description Mednax Inc provides physician services, which include newborn, anesthesia, maternal-fetal, teleradiology, pediatric cardiology, and other pediatric subspecialty care. The firm operates in six segments: neonatal and other pediatric subspecialties, anesthesia, maternal-fetal, pediatric cardiology, radiology, and other services. The neonatal segment contributes the largest proportion of the firm's revenue. Mednax generates virtually all of its revenue in the United States, with over half of its revenue from operations in five states: Texas, North Carolina, Georgia, Tennessee, and Florida. Contracted managed care payors contribute the majority of net collections.See more from Benzinga * Endo International: Q1 Earnings Insights * Newmark Group: Q1 Earnings Insights * Cooper Tire & Rubber: Q1 Earnings Insights(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Mednax (MD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

North American Partners in Anesthesia (NAPA) Acquires American Anesthesiology From MEDNAX, Inc.

MEDNAX Reports First Quarter Results Completes Sale of American Anesthesiology to North American Partners in Anesthesia

MEDNAX (MD) sells its American Anesthesiology to NAPA for portfolio rationalization and averting the negative COVID-19 impact.